# FDA Inspection 1123818 - Tesaro a GSK Company - May 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/tesaro-a-gsk-company/714e9037-e425-43d8-b4c2-23a9380c69a5
Source feed: FDA_Inspections

> FDA Inspection 1123818 for Tesaro a GSK Company on May 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123818
- Company Name: Tesaro a GSK Company
- Inspection Date: 2020-05-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1101895 - 2019-07-16](https://www.keypedia.com/records/fda_inspections/tesaro-a-gsk-company/859b1980-b1bd-4a8f-9ffb-04ba50eaf88a)
- [FDA Inspection 999778 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/tesaro-a-gsk-company/1f574bde-2813-429f-af5f-e2b6eb1f46ed)
- [FDA Inspection 924618 - 2015-04-01](https://www.keypedia.com/records/fda_inspections/tesaro-a-gsk-company/22fe9d68-5a98-43f0-9c01-903e592edd62)

Company: https://www.keypedia.com/companies/tesaro-a-gsk-company/f7d6b5b7-3b08-43dc-bed4-ea9f7d324858

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c